SC-101 (The First Affiliated Hospital with Nanjing Medical University)

N/A

Report date: 2026/04/03 20:03:44
NME

Base Information

Drug NameSC-101 (The First Affiliated Hospital with Nanjing Medical University)
Drug Alias NameSC101SC-101 (The First Affiliated Hospital with Nanjing Medical University)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHypertensionRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe First Affiliated Hospital With Nanjing Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital With Nanjing Medical University
Inactive CompaniesN/A
Active IndicationsHypertensionRenal Insufficiency, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A